Suppliers / Synbias Pharma

Synbias Pharma

Ukraine 7 employees Updated 9 July 2026

Synbias Pharma is an API manufacturer based in Ukraine. It holds 5 active US drug master files across a filed portfolio of 5 molecules.

5
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Doxorubicin SFDA (Saudi Arabia), US FDA 2
Epirubicin SFDA (Saudi Arabia), US FDA 2
Idarubicin US FDA 1
Nelarabine US FDA 1
Valrubicin US FDA 1

Also appears on these molecule pages

Doxorubicin API Epirubicin API Nelarabine API

Questions about Synbias Pharma

Does Synbias Pharma hold a US DMF or a CEP?
Synbias Pharma holds 5 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Synbias Pharma make?
5 molecules are on record against Synbias Pharma, including Doxorubicin, Epirubicin, Idarubicin and Nelarabine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Synbias Pharma?

Ask Fred what the record holds on Synbias Pharma, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Olon shares 2 molecules Hisun Pharmaceutical shares 2 molecules Dzd (Heze) Pharmaceutical shares 2 molecules MicroBiopharm Japan shares 2 molecules MSN Laboratories shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability